Shilang(Zhuoli Group)-Pharma(Nanjing) Co.,Ltd

Shilang(Zhuoli Group)-Pharma(Nanjing) Co.,Ltd
1 2 3
Shilang (Zhuoli Group)-Pharma (Nanjing) Co., Ltd. is a high-tech enterprise which is located in Nanjing, relying on the scientific research strength of China Pharmaceutical University, Nanjing University, and Nanjing University of Chemical ...
Read more

Product Showcase

New Products

Company Profile

Basic Information

Company Name: Shilang(Zhuoli Group)-Pharma(Nanjing) Co.,Ltd  Authenticated and Verified
Business Type: Manufacturer  
Product/Service
(We Sell):
Sucralose,Neotame,Moxifloxacin,Moxifloxacin Hcl,4-AA,4BMA,MAP,Meropenem  
Brands: IWIS  
Number of Employees: 501 - 1000 People 

Trade & Market

Main Markets: North America
South America
Eastern Europe
Southeast Asia
Eastern Asia
Western Europe
Trade Shows: 2009
1) FIC 2009
March 25-27, 2009, International Exhibition Centre (INTEX), Shanghai
Our Booth No. 8L05

2) IFT 09
June 06-09, 2009, Anaheim Convention Center, Anaheim/OC, CA

3) CPHI Shanghai 2009
June 23-25, 2009, Shanghai New International Expo Centre (SNIEC)

4) CPhI Worldwide Spain 2009
October 13-15, 2009, IFEMA, Feria de Madrid

2007-2008

1) CPHI China 2007
19~21 June
Shanghai New International Expo. Center(SNIEC)

2) FIC Shanghai 2008
26~28 March
Shanghai

3)CPHI China 2008
24~26 June
Shanghai New International Expo. Center(SNIEC)
Stand No.:E4A42  

Factory Information

Factory Size (Sq.meters): Above 100,000 square meters  
Factory Location: Zhuoli Zoon, Linyi, Yuncheng, Shanxi, China  
QA/QC: In House  
Number of Production Lines: 6  
Number of R&D Staff: 11 - 20 People  
Number of QC Staff: 11 - 20 People  
Management Certification: HACCP   ISO 9000/9001/9004/19011: 2000   Others  
Contract Manufacturing: OEM Service Offered   Buyer Label Offered  
Send your message to this supplier

Company Info

Shilang(Zhuoli Group)-Pharma(Nanjing) Co.,Ltd
[China]
[Verified Member]

City: Nanjing
Province/State: Jiangsu
Country/Region : China

Business Type:Manufacturer

View Contact Details

Email this page Bookmark this page Print this Page